Evaluate blood pressure lowering drugs in hypertensive pregnant patients before caesarean delivery
Not Applicable
Completed
- Conditions
- Health Condition 1: null- Pregnant patients with hypertension
- Registration Number
- CTRI/2018/05/013709
- Lead Sponsor
- Department of Anaesthesiolgy
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 162
Inclusion Criteria
1. patients with systolic blood pressure more than or equal to 160 mmHg and/or diastolic blood pressure more than or equal to 110 mmHg
2. single or multiple pregnancy
3. gestational age >24 weeks
Exclusion Criteria
1. patients who did not consent
2. any known allergy to drugs used (hydralazine and labetalol)
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method time taken to reach adequate control of blood pressure (systolic blood pressure 140-150 mmHg and/or diastolic blood pressure 90-100 mmHg)Timepoint: every 2 minutes till control of blood pressure achieved
- Secondary Outcome Measures
Name Time Method 1. efficacy of drugs used (number of doses required for adequate control of blood pressure) <br/ ><br>2. number of patients who achieved adequate control of blood pressure <br/ ><br>3. incidence of persistent hypertension <br/ ><br>4. adverse effects of drugs used <br/ ><br>5. maternal outcomes <br/ ><br>6. fetal outcomesTimepoint: every 10 minutes till adequate control of blood pressure